wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38567506-DEB391D9-423E-4ABB-A6D3-1D7168C5B671
Q38567506-DEB391D9-423E-4ABB-A6D3-1D7168C5B671
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38567506-DEB391D9-423E-4ABB-A6D3-1D7168C5B671
Vascular Smooth Muscle as a Target for Novel Therapeutics.
P2860
Q38567506-DEB391D9-423E-4ABB-A6D3-1D7168C5B671
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38567506-DEB391D9-423E-4ABB-A6D3-1D7168C5B671
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
688f0eb5663ef68bbc4f62f9a316d82fdbbf3056
P2860
Liraglutide attenuates high glucose-induced abnormal cell migration, proliferation, and apoptosis of vascular smooth muscle cells by activating the GLP-1 receptor, and inhibiting ERK1/2 and PI3K/Akt signaling pathways.